TAG:
Quest Diagnostics
An Insider’s Observances of Lab Outreach Deals
By R. Lewis Dark | From the Volume XXXII, No. 12 – August 25, 2025 Issue
THERE ARE MANY WAYS TO VIEW CLINICAL LABORATORY OUTREACH ACQUISITIONS and the enormous amount of money changing hands in these deals. From one point of view, those fearful of the continued expansion of national lab giants like Labcorp and Quest Diagnostics may shive…
At ADLM 2025, Spotlight Shines on Relationships
By Scott Wallask | From the Volume XXXII, No. 11 – August 4, 2025 Issue
CEO SUMMARY: At the ADLM conference, a new industry survey about the dynamic relationship between medical laboratories, physicians, and patients presented a strong argument for labs taking the lead in communicating and being more accessible to their colleagues. A troubleso…
News Briefs on Alzheimer’s Detection
By Scott Wallask | From the Volume XXXII, No. 9 – June 23, 2025 Issue
FDA-cleared IVD could replace scans There has been a significant amount of activity in recent weeks as it concerns tests to detect Alzheimer’s disease. Clinical labs and neuropathologists will want to keep a cl…
As 23andMe Faces Bankruptcy, Home Testing Shows Warts
By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue
HIGH-STAKES DRAMA SURROUNDING 23ANDME’S BANKRUPTCY—including CEO Anne Wojcicki resigning to try to bid for the company she cofounded and state prosecutors urging caution about the data privacy of the company’s customers—brings up a fundamental question regarding d…
Quest, Labcorp CEOs Discuss Tariff Strategies with Investors
By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue
Leaders at Labcorp and Quest Diagnostics indicated that they are prepared to weather at least the early months of the unfolding tariff war that is upending the global economy. “There will be some impact from …
May 12, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue
Yet another clinical laboratory has sold off part of its services to a national commercial lab. Labcorp announced on April 21 that it had finalized its acquisition of North Mississippi Health Services’ (NMHS) ambulatory outreach laboratory business. A…
In the Past, Labs Used Courts to Thwart Feds
By Robert Michel | From the Volume XXXII, No. 6 – April 21, 2025 Issue
CEO SUMMARY: A federal judge’s recent decision to vacate the FDA’s final rule on laboratory developed tests harkens back to a 2008 case where clinical labs stopped a CMS competitive bidding project. In the earlier case, legal risks led the government to back down. The …
Quest Acquires ‘Select Assets’ of Fresenius Medical Care
By Robert Michel | From the Volume XXXII, No. 4 – March 10, 2025 Issue
FRESENIUS MEDICAL CARE AND QUEST DIAGNOSTICS AGREED TO A DEAL in which Quest will provide laboratory testing services for the latter’s dialysis clinics in the United States. Separately, Quest Diagnostics will acquire “select assets” of Spectra Labora…
Quest Diagnostics, Labcorp Issue Q4 and Full Year 2024 Earnings
By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue
LAB ACQUISITIONS IN 2024 WERE A CONTRIBUTING FACTOR TO REVENUE GROWTH at the nation’s two biggest clinical laboratory companies. This was reflected in the fourth quarter and full year 2024 earnings reports issued by Labcorp and Quest Diagnostics. Here are recently …
February 17, 2025, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXII, No. 3 – February 17, 2025 Issue
To implement a corporate restructuring, Becton Dickinson (BD) announced on Feb. 5, 2025, that it would proceed to “separate BD’s Biosciences and Diagnostic Solutions business from the rest of BD.” The company plans to complete this action by the end of 2025. Clinical laboratori…
CURRENT ISSUE

Volume XXXII, No. 12 – August 25, 2025
In an exclusive interview, a laboratory industry M&A specialist discusses what’s driving lab outreach sales to national lab companies. Also, The Dark Report analyzes ways in which pathology and clinical labs can profitably partner with pharmaceutical companies.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report
1000 N West Street, Suite 1200 Wilmington, Delaware, United States, 19801
Phone: 512-264-7103
Email: info@darkreport.com
© 2025 The Dark Report. All rights reserved. Part of the LabX Media Group